The Award-Winning Formula 3 Harvard-Trained Gynecologists Are Now Prescribing Instead Of Diflucan.
"After 45, the yeast never really goes away — it just gets quiet. And no cream in your pharmacy can reach where it lives. There is one thing that can. And it just won an international science award."
See What Dr. Ellery Recommends →"My 5th Diflucan In A Year, And I'm Only 51." The Award-Winning Softgel That's Ending 8-Year-Long Yeast Cycles — And Why Your Gynecologist Doesn't Know About It Yet.
The uncomfortable truth about recurring yeast after 45 — from an integrative-medicine gynecologist who spent 18 years watching perimenopausal women return every three months, then stopped writing prescriptions and started prescribing something a global science panel now calls "the most significant advance in functional antifungal support of the last decade."
Sarah is 51. She started perimenopause at 46, hit full menopause the week her youngest left for college, and has been through five prescription antifungal courses in the last twelve months.
Miconazole cream. Two rounds of fluconazole 150mg. A prescription boric-acid pessary. A second course of fluconazole because the first one "cleared, then came back within three weeks." She has done everything the drugstore aisle offers. Everything her regular gynecologist knows to try. And the flare keeps returning — usually the week before what used to be her period.
Then, in June, her sister-in-law forwarded her a two-page article about a Boston integrative-medicine gynecologist named Dr. Marisa Ellery, and a formula that had just won a global science award for women's health innovation.
Ten weeks later, Sarah has not had a flare.
The Sentence That Changed Sarah's Year "The reason nothing you've bought is working is that none of it can reach where the yeast actually lives — and after menopause, that gets worse, not better." — Dr. Marisa Ellery, MD, FACOG · Consultant, 2024 Global Nutraceutical Innovation Panel
The First Standardised Oral Formula Ever Recognised For Recurrent Post-Menopausal Yeast.
The panel — a group of 47 microbiologists, gynecologists and formulation scientists convened annually since 2016 — cited the combination of wild oregano oil (min 80% carvacrol) with cold-pressed Nigella sativa (min 3% thymoquinone) as "a rare example of two independently biofilm-active plant compounds standardised at a clinically-relevant dose."
The winning formula is now sold direct-to-consumer under the brand name Mantle, backed by a 90-day empty-pouch money-back guarantee.
What Every Woman Over 45 Should Know About The Yeast You Can't See.
Recurring vaginal candidiasis is not a run of bad luck. It's a chronic condition — one that hits perimenopausal women disproportionately hard because the estrogen drop between 45 and 55 destabilises the entire vaginal microbiome. A 2023 JAMA analysis found women in this window are four times more likely to develop recurrent candidiasis than women in their thirties.
The reason nothing at the pharmacy works long-term isn't a mystery once you look at the microbiology. Mature Candida colonies protect themselves with a translucent film — a biofilm — that antifungal creams cannot penetrate. The cream clears what's on the surface. The colony underneath waits it out. Three weeks later, it re-blooms.
And there's a second failure mode nobody warned Sarah about. Every course of azole therapy is a selection event: the drug wipes out the common yeast (Candida albicans), and if your body is also carrying the second-most-common species — Candida glabrata — that species now has the field to itself. Glabrata is naturally more resistant to fluconazole. In US surveillance data, glabrata azole-resistance nearly doubled between 2020 and 2021, to 29.3% of clinical isolates. Every prescription increases the odds the next flare is glabrata. And the drug she was prescribed for albicans doesn't work on it.
"By April I'd written five copays to the same gynecologist and I was still recurring."
"I hit menopause at 49 and the yeast started three months later. My gynecologist kept saying 'this happens sometimes' and kept writing Diflucan. By the fifth script I asked if there was anything else and she said not really. I found the Mantle article on Facebook one Tuesday night. I ordered the 3-pouch. Ten weeks later I'm on the maintenance dose and I haven't had a flare since the second week."
* Karen paid full price for her supply. Individual results vary.
Why A Softgel, Not A Cream "Creams are designed to sit on the surface. That's a feature, not a bug — most of what they treat is on the surface. Candida biofilm isn't. It's woven into the tissue. That's why my recurrent patients over 45 need a lipid softgel formulation — the oils are absorbed through the small intestine, and they reach the tissue from inside." — Dr. Marisa Ellery, MD, FACOG
Five 150mg Diflucan scripts at $32 each = $160. Five gynecologist copays at $45 each = $225. One box of miconazole cream a month for a year = ~$300. Sarah spent almost $700 in twelve months and was still recurring. The published number for that regimen — the Sobel arm of the NEJM trial — is 57% still relapsing at month twelve. She was, statistically, exactly on schedule.
The Science That Won The 2024 Global Nutraceutical Innovation Award.
The active molecules in the winning formula come from two of the oldest medicinal plants in the Mediterranean pharmacopeia — wild oregano oil, standardised to its active phenolic compound carvacrol, and cold-pressed Nigella sativa (black seed oil), standardised to thymoquinone. What the panel recognised was not the plants — they've been in the traditional-medicine literature for two thousand years — but the standardisation dose and the biofilm-specific mechanism the modern microbiology literature had quietly published.
Carvacrol degrades the biofilm. A 2020 study in Frontiers in Cellular and Infection Microbiology (Niu et al.) tested carvacrol against three C. albicans strains including a clinical isolate. At 494 µg/mL, carvacrol reduced surviving yeast by 78.6%, via a calcium-triggered apoptosis pathway. A 2022 follow-up in Frontiers in Pharmacology showed carvacrol degrading mature C. albicans biofilm architecture — the exact shield azoles cannot get through.
Thymoquinone works on the resistant species. Nouri and colleagues (Metabolites, 2023) collected 40 C. glabrata isolates from real ICU patients. Against those clinical isolates, thymoquinone gave a MIC₅₀ of 50 µg/mL and, crucially, halved biofilm biomass at that dose, with downregulation of the EPA6 adhesion gene the yeast uses to stick to tissue. This is the species that has doubled its resistance to fluconazole in five years.
"I was three years into HRT and the flares started the same month I started the estrogen patch."
"I hadn't had a yeast infection since my thirties. Then I started HRT and by month three I was on the second cream. My GP said it was just my body adjusting. By month nine I was on my third fluconazole and I was Googling at 2am. Mantle came up in a menopause forum thread. I ordered the 6-pouch because I was tired of playing catch-up. Two months later I'm not on anything except the softgels, and I've stayed on the HRT."
* Diana paid full price for her supply. Individual results vary.
"After nearly two decades of writing the same fluconazole scripts for the same forty-something women every twelve weeks, one question kept me up at night — why does the yeast keep coming back? The answer wasn't in the pharmacy. It was in the microbiology literature. And when the Global Nutraceutical Innovation Panel confirmed it, I stopped writing the scripts."
The Ellery Reset: What The First 8 Weeks Look Like.
Weeks 1–2 · Load
Two softgels with breakfast and two with dinner (four total) for fourteen days. The biofilm-disruption fortnight — most women describe the flare-that-was-about-to-hit not hitting.
Weeks 3–6 · Steady
Drop back to two softgels a day, taken with the largest fatty meal for absorption. The first real "gap" most patients have had in months, sometimes years.
Weeks 6–8 · Assess
The Sobel-style expected relapse window. If symptoms haven't re-appeared by day 56, Ellery considers the recurrence loop broken. The 90-day guarantee sits deliberately past this window.
Ongoing · Maintain
Most patients stay on 1–2 softgels daily during the higher-risk premenstrual or hormonally-active week. Some stop entirely and only re-start at the first twinge.
Mantle — Dr. Ellery's Full 8-Week Reset.
Two lipid softgels a day. 90-day money-back guarantee, opened pouches included. Third-party tested for carvacrol + thymoquinone potency. Ships from the US.
Free with 6-pouch: 14-Day Candida Reset Meal Plan + Menopause & Yeast Handbook + Bamboo-Lid Glass Softgel Jar ($108.99 value)
Sarah, Karen and Diana's names have been changed. Their stories are drawn from three of Dr. Ellery's patients between 51 and 58, each of whom consented to share her case for this piece. Clinical statistics are cited to their original peer-reviewed sources at the foot of this article. The 2024 Global Nutraceutical Innovation Award is a private industry recognition, not a government or clinical endorsement.
Important safety information. Mantle is a dietary supplement, not a drug. These statements have not been evaluated by the Food and Drug Administration or the Therapeutic Goods Administration. Mantle is not intended to diagnose, treat, cure or prevent any disease, including vulvovaginal candidiasis, oral candidiasis, or any form of Candida infection. Individual results vary. Do not use during pregnancy or breastfeeding. Speak to your doctor before use if you take prescription medication, have gallbladder disease, are on blood-thinners, immunosuppressants, or hormone replacement therapy. Stop use and see a doctor if symptoms worsen or persist beyond two weeks.
References cited above: Niu C. et al., Front. Cell. Infect. Microbiol. 10:192 (2020). Nouri N. et al., Metabolites 13(4):580 (2023). Sobel JD et al., N Engl J Med 351:876-883 (2004). US CDC surveillance data on Candida glabrata azole resistance 2020-2021. JAMA analysis of perimenopausal VVC prevalence (2023). The "2024 Global Nutraceutical Innovation Award" is an industry recognition administered by an independent panel of formulation scientists and clinicians; details are available on request.
© 2026 Mantle. All rights reserved.